Clinical Trials in Seoul, Seoul Special City
3 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-Negative Breast Carcinoma+2 more
Olema Pharmaceuticals, Inc.1,000 enrolled85 locationsNCT07085767
Recruiting
Not Applicable
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
Breast Neoplasms
Asan Medical Center60 enrolled1 locationNCT06421285